As such, we compared its diagnostic performance among ATAD2, GPC3, and AFP (a traditional biomarker for HCC diagnosis) in 165 Asian cases (159 tumors and 6 nontumors) on the TCGA database. This evidence concerns the gene ATAD2 and hepatocellular carcinoma.